December 10th 2024
This paper explores the legal and regulatory framework around 3D drug printing, particularly for personalized medicine, considering regulatory compliance, business concerns, and intellectual property rights.
Flowsheet Models Modernize Pharmaceutical Manufacturing Design and Risk Assessment
In-silico design facilitates process optimization and evaluation of process control strategies.
Development Progresses in Continuous Solid-Dosage Manufacturing
December 17th 2014FDA funded projects at Rutgers' C-SOPS and at UMass Lowell to develop flow-sheet model algorithms for use in risk assessment, and start-up company Continuus Pharmaceuticals is making progress on their integrated system.